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In spite of several advances in healthcare, viruses are emerging and re-emerging as one of the significant reasons for 
morbidity and mortality on the planet. Currently, COVID-19 has arosed as the most fierce and affright viral infection to be 
handled by the human race, due to its nature of fast acceleration and slow deceleration. Neither vaccines nor drugs are currently 
available for prevention, prophylaxis and treatment of SARS-CoV2 infection in humans. Ayurveda, being the “science of 
holistic living and art of natural healing”, could offer potential solutions for the prevention and management of COVID-19 
infection. In this article, an attempt to find possible solutions by analysing the disease profile of COVID-19 using ayurvedic 
framework is made. Trividha bodhya sangraham is the guiding tool to analyse anukta vyadhi (novel or unsaid diseases). 
Different six levels of care i.e., preservation, promotion, protection, adjuvant/add-on, stand-alone and supportive recipes may be 
applied on case-to-case basis. Ayurveda based broad-spectrum antiviral agents could give extra assurance for everybody from 
novel viral diseases, reinforcing to leverage the potentials of Ayurveda. ‘NAMASTE’ is an acronym introduced to signify the 
protective measures of corona infection.  
Keywords: Anukta vyadhi, Ayurveda, COVID, Janapadodwamsa, NAMASTE 
IPC Code: Int. Cl.20: A61K 9/00, A61P 37/02, A61K 45/06 
Currently, world is facing burden of dual NCDs, one is 
non-communicable diseases such as Diabetes mellitus, 
Hypertension, COPD etc. and other one is novel 
communicable diseases such as SARS-CoV, SARS-
CoV2, Zika, Ebola, Nipah virus etc. Similarly we are 
also being effected with globalization, one aspect is 
‘Globalization of diseases’ (as the present condition 
COVID-19 effected almost all the countries in the 
world) and other aspect is ‘Diseases of Globalization’ 
may be due to mixing of cross cultural habits, foods, 
products etc. which has led to increased incidence and 
prevalence of diabetes, hypertension, cancer etc. 
 
Ayurveda is the indigenous system of healthcare 
developed in India with a method of reasoning 
legitimate establishment and it has made due as an 
unmistakable element from distant artifact to the 
current day1. The basics on which the Ayurvedic 
framework is based are valid for all times and eternal; 
contrarily Aristotle’s humoral theory is obsolete in 
modern medicine. Though Ayurveda is ancient in 
origin, but is so advanced in addressing the 
contemporary public health issues under the heading 
of ‘janapadodwamsa’.  
Janapadodwamsa (Pestilence-Devastating epidemics) 
Despite the individual dissimilarities in Prakriti, 
Ahara, Bala, Sathmya, Manas and Ayu; Vayu (Air), 
Udaka (Water), Desa (Geographical location) and Kala 
(Seasons) are the four major factors that are common for 
all inhabitants. These four factors, when polluted, affect 
all human beings simultaneously and results in 
ecological imbalance and causes Epidemics2. In a 
correspondence article published in Lancet journal, 
Wind (Vayu according to Ayurveda) was emphasized as 
a disregarded factor in the spread of irresistible illnesses. 
They demonstrated that breeze ought to be considered as 
a pivotal factor in the transmission of different illnesses, 
not simply those that are air-borne, on the grounds that it 
could balance the elements of various vectors and 
microorganisms3.  
As per Charaka, however, individual people vary 
generally in physical wellbeing and vitality, and they are 
aggregately at risk to annihilating pandemics brought 
about by external components. Punarvasu, analysing the 
root cause of the four fold pollution, says that ultimately 
human misdeeds of the present life or past life arising 
out of intellectual blasphemy (Pragnyaparadha) are 
responsible for all types of cosmic pollution and 
resultant ailments including large scale man slaughters 
with or without armaments (tatha sastraprabhavasya 
pi janapadoddvamsasyadharma eva hetur bhavati)4. 
————— 
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Oupasargika roga (Communicable diseases) - 
“Oupasargika roga samsarga jatah” - The diseases 
that are believed to occur from contact with affected 
person are known as Oupasargika roga. The different 
modes of disease transmission from one person to 
another are mentioned in Ayurveda like Prasangath 
(Sexual route), Gatra samsparsath (Direct and 
indirect body contact –direct physical contact includes 
hand shaking, kissing, hugging etc. and indirect 
contact includes touching contaminated surfaces, 
objects), Nishwasath (respiratory droplets and 
aerosols), Sahabhojanath (taking food along with 
diseased person), Sahasayyasanath (sitting and 
sleeping with afflicted person), Vastramalyanu 
lepanath (using the clothes, cosmetics and ornaments 
of patient). Acharya Sushruta mentioned diseases like 
Kushta (Leprosy and other skin conditions), Jwara 
(Fevers of epidemic origin like swine flu, Corona), 
Sosha (Pulmonary tuberculosis), Netrabhishyanda 
(Conjuctivitis) etc., are communicable from one 
person to another, as examples of Oupasargika roga56.  
 
Anukta vyadhi  
As COVID-19 is a new disease, it is unwise to 
expect an exact description of the disease in the 
ancient treatises. Based on the recommendations of 
Ayurveda with regard to new upcoming diseases i.e., 
Trividha bodhya sangraha7, the Ayurvedic literature 
was reviewed to identify the symptomatology that 
best describes the current presentation of patients with 
COVID-19 infection. With specific reference to 
Ayurveda, the entity, which isn't straightforwardly or 
explicitly referenced in Ayurvedic texts, is Anukta. 
Examples are diseases like Phiranga (Syphilis) and 
Upadansha (Gonorrhoea) are not described in earlier 
samhita because these diseases may not have existed 
at that time. However, even these diseases are 
described in ‘Bhavaprakash samhita8’ (13th BC) 
suggesting that they might have existed during the 
period in which the treatise was recorded.  
Concept of ‘Trividha bodhya sangraha’ has been 
described in Charaka Samhita. According to this 
concept the three entities i.e, Prakriti, Adhishtana and 
Samuttana need to be taken in to consideration for 
understanding any new or unknown disease that has 
not been explained in the samhita and also depicted as 
Fig. 1. By the application of these three tools, we can 
get the buddhatva (complete knowledge) of 
Anuktavyadhi. Vikara prakriti means the involvement 
of the dosha in samprati of a vyadhi and it should be 
identified along with the anshansha kalpana 
(permutations and combinations of doshas). 
Adhishtana is the place in the body where the dosha-
dushya sammurchana (accumulation after the 
amalgamation of vitiated dosha with weak and 
susceptible tissues) takes place and the disease is 
manifested. Samuttana are the causative factors. 
Samuttana also means disease symptomatology and 
healing and recovery from sickness.  
To begin with, based on the above Ayurvedic 
principles, the disease profile of COVID 19 was 
analysed and summarised in Table 1, 2 and 3. Later, 
formularies that were described in ancient texts to treat 
such symptoms and for samprapti vighatana (to break 
the vicious cycle of pathophysiology) were reviewed. 
And finally, based on the wisdom, experience and 
published evidences, different recipes are suggested.  
In agantuja jwaras, dosha vitiation happens later 
and manifests individual independent signs and 
symptoms based on the cause13. 
The signs and symptoms of COVID-19 can vary 
but over the course of the disease, most persons with 
COVID-19 will experience the symptom. CDC 
Interim Clinical Guidance for Management of 
Patients with Confirmed Coronavirus Disease 
(COVID-19)14 updated on April 3, 2020 detailed the 
symptoms (Table 3). Ayurvedic terminology nearly 
equivalent to symptoms given in parenthesis. 
Clinical course - The largest cohort of >44,000 
persons with COVID-19 from China showed that 
illness severity can range from mild to critical14: 
 
 Mild to moderate (mild symptoms up to mild 
pneumonia): 81% 
 Severe (dyspnea, hypoxia, or >50% lung involvement 
 
 
Fig. 1 — Trividhabodhya sangraham 




on imaging): 14% 
 Critical (respiratory failure, shock, or multiorgan 
system dysfunction): 5% 
 
In laboratory findings, Lymphopenia is the most 
widely recognized finding in COVID-19 and is seen 
in 83% of hospitalized patients. Lymphopenia, 
neutrophilia, raised serum alanine aminotransferase 
and aspartate aminotransferase levels, raised lactate 
dehydrogenase, high CRP, and high ferritin levels 
might be related with more prominent disease 
seriousness. 
 
The management of COVID-19 patients rely upon 
the clinical presentation, necessity for steady 
consideration, potential danger factors for creating 
serious infection, and the capacity of the patient to 
self-confine at home. Patients with hazard factors for 
Table 1 — Trividhabodhya sangraham & COVID-19 
Vikara Prakriti (disease constitution or template)  Vikara adhisthana (site) Vikara Samuttana (etiology) 
Dosha : Tridosha9 (Pancha vidha vata, Panchavidha pitta 
and panchavidha kapha) 
Dushya : Rasa and Rakta 
Srotas :Pranavaha and Rasavaha srotas mainly Udaka and 
Annavaha srotas secondarily  
Srotodushti : Sangam, Atipravritti and Vimarga gamanam  
Agni : Vishamagni (irregular) 
Ojas : Para ojas due to involvement of Hridaya – Ojo 
visramsa, vyapad and Kshaya  
Rogabala – Pravara (intense) 
Rogamarga : Abhyantara roga marga  
Vyadhi swabhava : Ashukari(accelerates very fast)and 
Chirakari (decelerates much more slowly)10 
Sadhyasadhyatah – Kricchra sadhya (difficult to cure) 
Udhbhava sthana :  
Kanta (throat) 
 
Vyaktha sthana : 
Uras(Chest region) -  
Phuppusa (Lungs) 
Direct cause -  
 Agantuja karana (Bhutabhisangaja11– Corona 
virus) 
 
Indirect cause –  
 Samsargaja(contact) 
 
Table 2 — Shatkriya  kala (six stages of samprapthi pathophysiology) of COVID 19 
S. No. Stage of kriyakala Pathological changes Remarks 
1 Chaya (accumulation) Viral entry - entry of SARS-CoV 2 into the body either by 
nasal/oral/eyes 
First four stages are falls under 
Incubation period. Incubation 
period is longer in kapha 
dominance, shorter in vata 
dominance and medium in pitta 
dominance12. 
Mild – moderate stage  
2 Prakopa (aggravation/ 
excerbation) 
Viral shedding due to virus-host interaction, evades immune 
system 
3 Prasara  
(spreading) 
Virus endocytosis - entry into the host cells thru’ ACE2 
receptors and also travels to lower respiratory tract  
4 Sthana samsraya (invasion) Viral replication leads to expression of milder symptoms 
(presymptomatic phase – purvarupa) 
5 Vyaktavastha (manifestation) Immune hyperactivity Virus-host interaction decides the full 
expression of symptoms  
Severe stage  
6 Bhedavastha (complications) Pulmonary destruction leads to respiratory failure, death Critical stage 
 
Table 3 — Comparative symptomatology of COVID-19 
Vikara samuttana (disease symptomatology) 
Typical   symptoms of Covid 19 Remarks  
 Fever (Jwara) (83–99%) 
 Cough (Sushka Kasa) (59–82%) 
 Fatigue (Glani) (44–70%) 
 Anorexia (anannabhilasha/Abhikshnamaharam) (40–84%) 
 Shortness of breath (Swasanadi nigraha) (31–40%) 
 Sputum production (Kasa)(28–33%) 
 Myalgias (Angamarda) (11–35%) 
 Madhayamavega jwara (low grade fever) is the typical feature of 
Vatakapha dominance 
 Tivra  jwara infers pitta dominance 
 Glani symptom infers involvement of ojas15 particularly in ojovyapath 
 Angamarda infers the involvement of Rasa dhatu 
Atypical symptoms of COVID 19 Remarks 
 Headache (shiro rodanam), confusion (sarvendriyahani), 
rhinorrhea (peenasa), sore throat (sushka kanta), hemoptysis 
(raktapitta), vomiting and diarrhea (chardi and atisara) 
 Anosmia (gandhanasha) or ageusia (aruchi) 
 Chardi and atisara are mentioned in Jwara upadrava 
 Tandra (stupor - improper functioning of sense organs – anosmia and 
ageusia) gives clue of ojovyapath 
 In bhutabhshangaja jwara varied symptoms are observed16 




creating serious sickness ought to be observed firmly 
given the conceivable danger of movement to extreme 
ailment in the second week after beginning of 
manifestations. As on date no specific treatment for 
COVID-19 is approved by FDA. Several clinical 
trials are underway testing different remedies with in-
vitro antiviral action against SARS-CoV-2 and 
additionally immunomodulatory impacts that may 
have expected clinical advantage. 
 
Possible solutions in Ayurveda 
World Health Organization (WHO) recommended 
inclusion of traditional medicine and practices in Risk 
communication and community engagement, Infection 
prevention and control & case management of COVID-
1917. WHO defined Traditional medicine as “It is the 
sum total of the knowledge, skill, and practices based 
on the theories, beliefs, and experiences indigenous to 
different cultures, whether explicable or not, used in 
the maintenance of health as well as in the prevention, 
diagnosis, improvement or treatment of physical and 
mental illness18. Traditional Chinese Medicine (TCM) 
was applied in the treatment provided for over 90 
percent of the COVID confirmed cases. Three TCM 
drugs and prescriptions have also been proved effective 
and were used in the treatment for most patients19-21. 
Ayurveda, Indian traditional healthcare knowledge 
system, has enjoyed an unbroken tradition of practice 
in India for thousands of years till now. TCM applied 
in Corona cases seems to have Ayurveda connection22. 
Reports from the Indian states support that Ayush 
system helps quarantined individuals dodge corona 
virus infections23.  
The prophylactic and therapeutic potential of 
traditional and complementary medicine systems such 
as Ayurveda and Yoga is not really being considered 
during this crisis and global hunt for effective 
preventive and treatment measures24. Traditional 
medicines are commonly overlooked in innovative 
work of contemporary drugs since their translational 
possibilities are regularly belittled. 
 
Pathogen-Host-Disease triad  
While planning the therapeutics, usually pathogen, 
host and disease are considered as targets either alone 
or in combination. 
1. Pathogen : SARS-CoV 2 
2. Host : Human being  
3. Disease : symptoms of COVID 19 
Pathogen host interaction and interface leads to the 
expression of the disease specific symptoms. This 
pathogen host interaction influences expression of 
symptoms, which may be mild, moderate, severe or 
critical.  
 
Different levels of COVID care in Ayurveda 
Based on the dictum of Ayurveda i.e. Swasthasya 
swasthya rakshanam, aturasya vikara prashamanam25, 
the following different levels of care can be offered from 
Ayurveda for COVID management.  
 
1. Preservation recipes – For the preservation of health 
of healthy individuals 
2. Promotion recipes – For promotion of 
Ojas/Rogibala/Immunity in healthcare workers and 
other frontline staff, vulnerable people such as 
elderly, patients with chronic diseases (DM, HTN, 
Asthma, COPD etc.), Pregnancy, Lactating mothers, 
children & Case suspects so as to prevent the disease 
3. Protection recipes - For the protection of health of the 
recovered cases from lingering infection or 
secondary attacks of reinfection or reactivation of 
CoVID-19. 
4. Adjuvant/Add-on recipes – in the case management 
as an adjuvant to standard care. 
5. Stand-alone/Mono therapy - only ayurvedic recipes 
shall be given in mild-moderate stages of the 
COVID-19 so as contain its progression to 
successive severe stages.  
6. Supportive recipes - Post recovery residual issues 
such as cough, breathing issues, PTSD etc. 
 
Prime Minister Narendra Modi in his address to the 
nation on April 14, 2020 had recommended Ayurveda 
guidelines to build the immunity in seven points of 
action (saptapadi) to prevent coronavirus infection26 and 
also reminded the same on April 26, 2020 in Mann Ki 
Baat monthly radio programme27. 
Generally in the cases of epidemics, we need such 
drugs which show instant effects. The drugs should 
possesses Rasayana property, Vishaghna property, 
Bhutaghna property, Pranavaha sroto specificity and 
then only they can show the fast acting effects in 
COVID cases. 
The following are the different recipes and 
supportive measures traditionally regarded as safe and 
effective –  
 
1. Pratismarsh nasya (intranasal application) –The 
lining of the nose rich in cells with ACE2 receptors 
and is the site of entry into the body28-30. Intranasal 
application of oil creates liphophilic medium which 
may inhibit hydrophilic virus. Anu tailam31 is 
specifically advised for intranasal application, as the 




ingredients of this medicine possess the antimicrobial 
effects. Plain sesame oil may also be used. It may be 
applied at preventive and promotive level of care. 
Science behind the application of sesame oil inside 
the nasal cavity and its protection against the viruses 
has been established hypothetically32.  
2. Dhuma nasya (medicated aerosol therapy) – 
medicated fumes from smoke of burning medicated 
herbs taken by nasal route and eliminated by the oral 
route. It has systemic therapeutic benefits 
particularly in respiratory problems. This can be 
used at all the levels of care. 
3. Gandusha (oil pulling/swishing)33 – beneficial to 
maintain good oral hygiene and to avoid the chances 
of microbial invasion34. Gandūsha stimulates the 
salivary glands to secrete more saliva, which 
contains a variety of host defence factors such as 
IgA, IgM antibodies and lysozymes and also 
balances the pH of the oral cavity35 it acts against 
micro-organisms by acting as local antibiotic. Plain 
sesame oil36 or cow’s ghee or Arimedadi tailam37 
can be used for gandusha. This can be used at all the 
levels of care. 
4. Lighting of Ghee lamps – It purifies indoor 
environment due to its vishagrahadi bhutaghnam 
effect or you may use beewax candles (bhutaghnam). 
This can be practiced on regular basis or else during 
corona season.  
5. Dhupana karma–this medicated fumigation therapy 
may be continued throughout the corona season. 
This may minimise the community transmission due 
to antimicrobial properties of medicated fumes and 
smoke.  
6. Muleti (Glycyrrhiza glabra –liquorice root) 
chai/doodh - Take 150 mL water/cow’s milk and 
boil it. While water/cow’s milk is boiling add 3-5 
gms fine powder of Muleti to it and allow the same 
to boil for one minute and then cover the vessel with 
a lid. After that stop the flame. Allow it for cooling 
for 1-2 min then sieve it and drink. This has to be 
continued throughout this Corona season. Daily you 
may consume in the morning and evening as per the 
comfort38. This can be used at all the levels of care. 
7. Haridrakhand39– Haldi (turmeric) is the major 
ingredient in this formulation. It is available in the 
granules form. It can be consumed with lukewarm 
water or warm milk on empty stomach. This can be 
used at all the levels of care. 
8. Samshamani vati40 (Giloyghan vati) – highly praised 
recipe for it’s immunomodulatory effects41,42. It 
maintains the homoeostasis of the doshas43. This 
drug has been mentioned in the advisory issued by 
Ministry of AYUSH44, Govt of India as preventive 
and prophylactic remedy.  
9. Saraswatarishta with Gold45 - Its therapeutic benefits 
are // balakanam cha younam cha vriddhanam cha 
sada hitha // naranari hitho nityam paramojaskaro 
matah // For all age groups of children, youth and old 
age persons and for both sexes it is beneficial all the 
times and can be taken regularly46. It is best immune 
booster. // amrita samah // It is equivalent to 
ambrosia or nectar. // akalamrityu haranam // - It 
Prevents untimely death and // rasayana varah // - 
Best immunomodulator. It is reported to have best 
free radical scavenging potentials47. And also studies 
proved its antidepressant effects48 which is essential 
in the quarantine (self and special) cases and PTSD of 
COVID-19 cases. It can be used at the different levels 
of care.  
10. Swarna bhasma – Gold quickly destroys all poisons 
even gara visha. Just as water fallen on lotus leaves 
cannot wet it, visha cannot destroy a person who is 
administered with swarna bhasma49. Researchers 
also established that Gold perpetuates “stemness”50 
and non-specific immunity51. 
11. Kanakasavam52-53 - Highly beneficial in all types of 
Swasa and Kasa, Yakshma, kshatakshinam, jirna 
jwara, raktapitta and urakshatam. Major ingredient 
in this formulation is Draksha which is considered 
as ‘phalottama’ (best fruit) (AH). Pharmacological 
effects are ‘brimhani’ (nutritive), kanthya (soothing 
effect on throat), virechanopaga, kasahara (relives 
cough), shramahara (relives fatigue) and also 
beneficial in swarabeda (throat disorder), dourbalya 
(fatigue), raktapitta (bleeding disorder), netraroga, 
(eye disorder) rajayakshma (tuberculosis), daha 
(burning sensation), trshna (thirst), jwara (fever), 
vamana (vomiting), shukra dourbalya 
(semendisorders). The main ingredient is “Dhatura’ 
whose pharmacological effects are balances vata 
and kapha, krimi (antimicrobial), vishapaha 
(antipoisonous). It can be used in recovered cases 
and also as add-on therapy in the COVID 
management.  
12. Tablet Fifatrol – It is an ayurvedic herbomineral 
proprietary drug. The composition of the 
formulation54 is aqueous dried extracts of Giloy 600 
mg, Daruhaldi 300 mg, Apamarga 200 mg, 
Chirayata 200 mg, Karanjbeej 200 mg, Katuki 100 
mg, Tulasi 100 mg, Musta 50 mg, and powders of 




Godanti bhasma 100 mg, Tribhuvankirti ras 60 mg, 
Mrityunjaya ras 60 mg, Sudarshanghan vati 60 mg, 
Sanjivani vati 60 mg, Processed in decoctions of 
Tulsi, Giloy and Apamarga. Researchers from 
AIIMS Bhopal have reported that Fifatrol can be a 
good substitute to allopathic antibiotics to treat 
infections, and that too without causing any side 
effects. But the Fifatrol drug has not only been found 
to enhance immunity but also found suitable in 
controlling spread of infectious diseases55. This drug 
can be used as monotherapy along with other 
ayurvedic drugs and/or add-on therapy in COVID 
management and also a drug of choice in recovered 
cases for symptom management.  
13. Mritasanjivani arishtam56 - Polyherbal hydro-
alcoholic formulation prepared by fermentation and 
distillation process. Therapeutic benefits are deha 
dardyakara (improves tonicity of the body), 
pushtikara (improves nourishment), balakara 
(promotes strength and immunity), agnivardhana 
(promotes digestion), sannipata (useful in life 
threatening conditions), ghora jwara (life threatening 
fevers), shete dehe (last resort to give life to a person). 
This drug can be used as monotherapy along with 
other ayurvedic drugs and/or add-on therapy in 
COVID management. This has to administer in 
frequent doses (muhurmhur). 
14. Shishubharan ras57 - It is an ayurvedic herbomineral 
proprietary drug. The composition of the formulation 
is Kumarakalyana ras 10 mg, Sitopaladi churna 150 
mg, Sanshamani vati 20 mg, Madhumalini vasant ras 
20 mg processed in Draksha. This combinations 
seems to more ideal targeting all the clinical areas of 
this COVID-19. This drug can be used as 
monotherapy along with other ayurvedic drugs and/or 
add-on therapy in COVID management. This drug 
can also be used in recovery cases as per the need.  
15. Kas shwas hari ras58- It is an ayurvedic herbomineral 
proprietary drug. The composition of the formulation 
is Shwaskas chintamani ras 10 mg, Nardiya 
lakshmivilas ras 50 mg, Sootasekhara ras 50 mg, 
Talisadi churna 120 mg processed in Vasa. This 
combinations seems to more ideal targeting all the 
clinical areas of this COVID-19. This drug can be 
used as monotherapy along with other ayurvedic 
drugs and/or add-on therapy in COVID management. 
This drug can also be used in recovery cases as per 
the need. 
16. Classical ayurvedic formulations such as 
Sameerpannag ras, Gorochanadi gulika, Brihat 
Kasturibhairav ras, Swasanandam gulika, Vayu 
gulika, Vettumaran gulika, Sheetamshu ras etc are the 
drug of choice as per the severity of the symptoms.  
17. Proprietary formulations such as Swasakalp syrup, 
Swaskalp tablet, Shwasamritam granules etc are 
also beneficial based on the ingredients of the 
formulations. They can also be used at different 
levels of care as per the need and availability. 
18. Trivrit lehyam59– as it is known fact that the virus 
remains in the body even after the clinical and 
biochemical recovery from COVID-19. Considering 
the principle of “jwara mukte virechanam” it is ideal 
to advise Trivrit lehyam (trivruth possesses 
vishaghna property) to remove the viral antigens 
from the body. So it is advisable in recovered cases 
and also cases with residual issues. 
19. Agastya rasayanam – Classical ayurvedic herbal 
formulation. Benefits are Ayubala vardhanam 
(enhances lifespan, strength), sreshta rasayana (best 
immunostimulant) and indications are panchavidha 
kasa, hikka, kshaya, vishama jwara, pinasa, aruchi, 
hridroga etc.This drug can be used in recovery 
cases to enhance the immunity and to relieve the 
lingering symptoms. This drug has been mentioned 
in the advisory issued by Ministry of AYUSH60, 
Govt of India for symptom management and add-on 
therapy.  
20. The jwara caused by shapa (curse), abhichara 
(tantric rituals with evil purpose), bhutabhishanga 
(affliction by micro organisms or evil spirits), daiva 
vyapashraya chikitsa (performance of spiritual 
therapies) is the most desired therapy 
(Ch.Chi.3/317).  
21. Ayurveda strongly emphasizes on diet and lifestyle 
modification in the management of the diseases, 
which is also applicable to this condition.  
 
Scientific rationale of some Ayurvedic drugs & 
measures –  
 
A. Yashtimadhu - Glycyrrhiza glabra (liquorice) root 
Pharmacological effects of Yashtimadhu are 
Jivaniya (vivifying - To give or bring life to), 
Angamarda prashamana (pacifies fatigue), 
shonithasthapana (styptic), Dahaprashamana 
(pacifies burning sensation in Jwara), Kantya (soothes 
oropharynx), Rasayana (Immunomodulator), 
Tridoshahara (pacifies all three dosha). Studies also 
proves that Yashtimadhu have specific effects against 
SARS-CoV61-63.  
Almost 3500 research articles of Glycyrrhiza 
glabra are available on Pubmed64. Major active 




constituent of Yashtimadhu is Glycyrrhizin. 
Glycyrrhizin is a saponin-like compound that gives 
the fundamental sweet flavor for licorice, with 
potential immunomodulating, anti-inflammatory, 
hepato- and neuro-defensive, and antineoplastic 
effects. Glycyrrhizin regulates certain enzymes 
involved in inflammation and oxidative stress, and 
downregulates certain pro-inflammatory mediators, 
thereby shielding against inflammation- and reactive 
oxygen species (ROS)-induced damage65.  
Glycyrrhizin is considered under Broad-spectrum 
antiviral agent66 (BSAA). The BSAAs hinder viral or 
host factors and block viral replication, diminish the 
viral burden to a level at which host immune 
responses can manage it or encourage apoptosis of 
infected cells67. BSAAs could be combined with other 
antiviral agents or combinations of 2–3 BSAAs to 
obtain synergistic or additive effects against certain 
viruses or to target an even broader range of viruses. 
Such combinations could serve as front line 
therapeutics against poorly characterized emerging 
viruses or re-emerging drug-resistant viral strains68,69. 
Glycyrrhizin is found to inhibit the wide range of 
viruses70 such as as Hepatitis C virus (HCV), 
Enterovirus A (HEV-A), Enterovirus B (HEV-B), 
SARS-CoV, Influenza A virus (FLUAV), Human 
Parainfluenza Virus 2 (HPIV2), Epstein-Barr virus 
(EBV), Herpes simplex virus 1 (HSV-1), Kaposis 
Sarcoma associated Herpes virus (KSHV), Rubella 
virus (RV) and HIV-1 in cell culture studies. 
 
B. Guduchi (Tinospora cordifolia (Willd.) Miers ex 
Hook and Thomas) 
The sanskrit term for Tinospora cordifolia is 
guduchi which means ‘protects from diseases’ and 
other synonym is ‘amrita’ which means ‘like ambrosia 
or nectar makes immortal’. Pharmacological effects of 
Guduchi are Tridoshahara (pacifies tridosha), 
rasayana (immunomodulaor), Balya (gives strength), 
agnidipani (promotes digestion), Kasahar (relieves 
cough), vishagni (antipoisonous), jwarabhutaghni 
(Anti-viral fever), Vayahsthapana (stabilizes ageing), 
chakshushya (promotes vision)71 etc.  
Almost 400 research articles on Tinospora 
cordifolia are available on Pubmed72. 
Tinospora contains almost 50 diverse phytochemicals 
including alkaloids, phytosterols, glycosides, lignans, 
terpenids and mixed other chemical compounds73. 
Most of these active compounds are known for 
immunomodulatory (α-Dglucan, G1-4A, N-
formylannonain etc), anticancer (berberine, palmatine, 
clerodane furano diterpene etc) and rest as antioxidants, 
all these compounds are effective against oxidative, 
inflammatory and cancerous disease directly or 
indirectly through series of chemical processes74. 
Tinospora cordifolia can be used as a source of 
berberine and possible anti-inflammatory activity of 
Tinospora cordifolia may be attributed to the presence 
of berberine75.  
Berberine is an organic heteropentacyclic compound, 
an alkaloid antibiotic, a botanical anti-fungal agent 
isolated from many kinds of medicinal plants76. It 
interacts directly with nucleic acids and with several 
proteins, including telomerase, DNA topoisomerase I, 
p53, NF-kB, MMPs and estrogen receptors. Preliminary 
clinical proof endorse the capacity of berberine to reduce 
endothelial inflammation enhancing vascular wellbeing, 
even in sufferers already stricken by cardiovascular 
diseases78. 
Results of a study demonstrated that berberine 
emphatically stifled viral replication in A549 cells and in 
mouse lungs. It additionally eased respiratory 
inflammation and decreased necrosis, incendiary cell 
penetration, and pneumonic edema actuated by viral 
contamination in mice in comparison with vehicle-
treated mice. Berberine smothered the viral 
contamination initiated up-regulation of TLR7 signaling 
pathway, such as TLR7, MyD88 and NF-κB (p65), at 
both the mRNA and protein levels. Besides, berberine 
fundamentally hindered the viral contamination initiated 
increment in Th1/Th2 and Th17/Treg proportions as 
well as the pro-inflammatory cytokines production79. 
Berberine is also considered under Broad-spectrum 
antiviral agents80. Berberine is found to inhibit the wide 
range of viruses70 such as Chikungunya virus (CHIKV), 
Hepatitis C virus (HCV), Enterovirus A (HEV-A), 
Enterovirus B (HEV-B), Sindbis virus (SINV), Zika 
virus (ZIKV), Influenza A virus (FLUAV), Respiratory 
syncytial virus (RSV), Cytomegalic virus (CMV), 
Human papilloma virus (HPV), Herpes simplex virus 1 
(HSV-1) and HIV-1 in cell culture studies.  
 
C. Haridra (Curcuma longa) 
The sanskrit term haridra means ‘liked by lord Hari’ 
and also means ‘which improves skin complexion and 
cleanses skin’. Pharmacological properties are 
Krimighni (antimicrobial), vishaghna 
(antipoisonous/viral), sleshmashamana (pacifies kapha), 
vishodhini (natural detoxifier), Pinasanashini (relieves 
rhinorrhea)81 etc.  
Almost 15000 research articles of Curcuma longa are 
available on Pubmed82. Curcumin is a characteristic 




component of the rhizome of haridra. Curcumin hinders 
the formation of reactive-oxygen species, has mitigating 
properties because of restraint of cyclooxygenases 
(COX) and different chemicals associated with 
inflammation and upsets cell signal transduction by 
different mechanisms including hindrance of protein 
kinase C83. Curcumin also shows protective effects on 
Lung Inflammatory and Structural cells as in  
Fig. 2(ref.84) which is much needed in the management of 
COVID-19 cases. 
 
D. Kalmegha or Bhunimba (Andrographis paniculata) 
Pharmacological properties of Bhunimba are Katu 
vipaka, sheeta virya, laghu ruksha guna, tikta ras, 
kaphapitta har, dipana, jwaraghna, krimighna, rechana, 
pittasaraka etc. The main active constituent of 
Bhunimba is Andrographolide85. Andrographolide could 
be a labdane diterpenoid incorporates wide extend of 
restorative applications counting anti-inflammatory, 
anti-platelet conglomeration exercises and potential 
antineoplastic properties. The proposed mechanisms of 
broad spectrum effects of this phytomolecule are –the 
mitigating effects of this agent have all the earmarks of 
being identified with the restraint of nitric oxide (NO) 
creation by macrophages. This agent may initiate the 
NO/cyclic GMP pathway and repress both the 
phospholipase C gamma 2 (PLC gamma2)/protein 
kinase C (PKC) and PI3K/AKT-MAPK flagging 
pathways in enacted platelets to hinder platelet 
collection. In initiated platelets, these three flagging 
pathways are downstream of integrin enactment 
interceded by collagen binding and impact the 
relationship of fibrinogen with its receptors. Moreover, 
andrographolide may apply its enemy of disease 
movement through the enlistment of cell cycle capture at 
G0/G1 stage and the incitement of lymphocyte 
expansion and initiation. These cycles could bring about 
diminished multiplication of and expanded 
immunocytotoxicity against tumor cells86. 
An in silico study on Andrographolide as a potential 
inhibitor of SARS-CoV-2 main protease found that 
Andrographolide was docked effectively within the 
binding site of SARS-CoV-2 Mpro. Computational 
approaches moreover predicts that this molecule to have 
great dissolvability, pharmacodynamics property and 
target precision. This molecule too complies Lipinski's 
rule, which makes it a promising compound to seek after 
advance in biochemical and cell based tests to 
investigate its potential for use against COVID-1987. 
Different studies also reported antiviral activities of 
Andrographolide against HBV88, HIV-189,90, HSV-191-93, 
Influenza virus94, Epstein Barr virus95, CHIKV96; 
immunomodulatory effects97-99 and its specific effects on 
upper respiratory tract and lungs100-105. The formulation 
having Bhunimba as an essential ingredient reported to 
have antiviral properties106-107.  
 
E. Punarnava (Boerhaavia diffusa) 
Pharmacological properties are vatakapha hara 
(mitigates vata and kapha dosha), Kasahara (relieves 
cough), vayah sthapana (stabilizes ageing), hridroga 
(heart disease), Swasa (relieves breathlessness), shotha 
(relieves edema), pandu (relieves anemia), kaphapaha 
(relieves sputum), garavisha (relives toxic conditions) 
etc.  
A systematic review and meta-analysis study found 
that "use of ACE inhibitors was related with a 
significant reduction in chance of pneumonia by 34% 
when compared with controls." Besides, "the chance of 
pneumonia was too diminished in patients treated with 
ACE inhibitors who were at higher risk of pneumonia, 
in specific those with stroke and heart failure108." 
Coincidentally Punarnava was reported to have ACE 
inhibitory activity109-111.  
 
F. Dhatura (Datura metel) 
Sanskrit term dhatura means ‘it squeezes sleshmadi 
dhatu’. Its synonym is ‘shivapriya’ means liked by 
Lord shiva. Ayurveda considers COVID-19 as Jwara 
epidemic which is due to ‘Rudrakopa’ (aggression of 
 
 
Fig. 2 — Protective effects Curcumin on Lung inflammatory and
structural cells84. 




Lord Shiva). Pharmacological effects are balances 
vata and kapha, krimi (antimicrobial), vishapaha 
(antipoisonous) etc. 
 
Coincidentally the spherical structure of corona 
virus with spikes simulates with thorn apple i.e., fruit 
of Datura metel as Delete in Fig. 3. This is also 
considered as basis for the selection of the drug as per 
Ayurveda, which may show its effects against corona 
virus by prabhava effect. So studies on this drug are 
also area of research.  
 
G. Lasuna (Allium sativum) (Lasuna) also regarded 
to target the viral replication of SARS-CoV, springing 
up as promising candidates towards SARS-CoV-2112. 
From the above descriptions it is clear that, these 
are compelling evidences that medicinal herbs may be 
a first line of protection in opposition to infectious 
sicknesses. Indian medicinal plants are probably to be 
ability drugs for potential remedy of COVID-19. It 
may be recommended that conventional Indian 
medicinal plants as possible novel healing agents 
targeting on SARS-CoV-2 and its pathways. Hence, 
by means of repurposing the Indian medicinal plants, 
more revolutionary remedy options can be penned 
down for their role in defeating this viral 
transmission. 
 
H. Dhupana karma – Ayurvedic fumigation therapy 
Therapeutic aerosol delivery has been an essential 
methods of treating lung conditions. In ancient times, 
therapeutic aerosols were frequently delivered by 
smoking or setting home grown blends in a warmed 
compartment and breathing in the subsequent 
fumes113. Fumigation therapy is one of the treatment 
strategies portrayed in Ayurveda whereby exhaust 
delivered from characterized medicated formulations 
are breathed in by patients (dhupana nasya). 
Ayurveda suggests fumigation as a technique for 
cleansing and remedial methodology for different 
human maladies including microbial diseases and 
mental issues114. Results of a study suggest that the 
combustion process in smoke inhalation therapy 
produces an ‘extract’ with superior antimicrobial 
activity115 and also a study reported from IIT Madras 
in 2016 on isolation, characterization, and application 
of the carbon nanomaterial from turmeric smudges 
demonstrated the antibacterial effect of turmeric 
smudges and validated the crucial role that the nano 
carbon play in the ethanopharmacological aspect of 
turmeric smudges116. 
Aparajitha Dhooma choornam is mentioned in 
Ayurvedic texts in the context of Jwara Chikitsa for 
fumigation. The fumigation prevents the spread of 
infectious fever and also disinfects the air from 
pathogens. Study also establishes the antimicrobial 
activity of Aparajitha Dhooma choornam117. 
 
I. The ‘behavioural immune system’ is composed of 
mechanisms that evolved as a means of facilitating 
behaviours that minimized infection risk and enhanced 
fitness118. Use of face masks, hand hygiene and 
respiratory etiquette are simple cost-effective 
behavioural interventions to prevent the infections in the 
community particularly in vulnerable populations. This 
in due course develops behavioural immune system.  
 
Discussion  
Always pandemics poses challenges to the science; 
which make us to think out-of-box so as to innovate 
and to generate evidence to prove the same and in turn 
to save lives. For Ayurveda, it is the right opportunity 
to generate data and valuable evidence on its use to 
beat COVID-19. In this context the words of Prime 
minister of India Narendra Modi holds relevant i.e., 
"world will surely accept our ages old Ayurvedic 
principles like yoga, provided the same has to be 
explained to the world in a scientific language, so that 
they understand it" reminds entire Indian scientific 
fraternity to work for our own strength and glorious 
tradition of Ayurveda119. In the name of ‘evidence’ 
researchers look at Ayurveda from the perspective of 
conventional drug discovery which is based on ‘one’ 
paradigm i.e. one molecule-one target-one effect-one 
disease approach which is quite opposite to the 
Ayurvedic principles i.e., multiple constituents-multi 
targets-synergistic effects-different diseases. Most of 
the Ayurvedic research on drugs is not on discovery 
rather it is ‘rediscovery’ in a sense of understanding the 
mechanism of drug efficacy. If we try to apply one 
paradigm approach to Ayurveda so as to generate 
evidence, all efforts will go in vain.  
 
Fig. 3 — Morphological simulation of thorn apple and corona 




The purpose of any science is to help the mankind. 
For the benefit of mankind, modern physicians and 
scientists may keep their ‘ego of science’ aside, think 
of our own knowledge system of healthcare – 
Ayurveda which is evolved and existed since 
centuries on this land; in the interest of public health 
in crucial times. Just on the reason of ‘lack of 
evidence’ one cannot keep Indians deprived of 
Ayurvedic drugs during this critical time.  
 
Conclusion  
WHO Director-General in a virtual media briefing of 
COVID-19 from Geneva on 13 April 2020 said that, 
“The way forward is solidarity: solidarity at the national 
level, and solidarity at the global level”120. Our 
perception of solidarity is ‘solidarity among available 
healthcare systems in the interest of public health to find 
the cure for SARS-CoV2 is the need of the hour. If the 
traditional medicines are allowed for the use in the cases 
of COVID -19 as add-on therapy or monotherapy on the 
basis of their usage in the society since centuries in the 
similar symptomatology and also on the grounds of 
marijuana use by Pennsylvania121; definitely this combo 
of integrative medicine will become “biggest game 
changers in the history of medicine”.  
Different levels of COVID care as discussed and 
detailed in the article are applied in true spirit, then 
Ayurveda can definitely create a huge impact in the 
containment of COVID-19. Ongoing uncertain situation 
of COVID -19 reminds us about the basic premise of the 
management i.e., Prevention is better than cure, because 
viral diseases are hard to cure and once contacted, they 
can be life-threatening. Considering the gravity of the 
situation, It is apt to say that Prevention is only and 
ultimate cure of COVD- 19. Prevention and protective 
measures for COVID-19 are given as an acronym 
NAMASTE - No to Handshake, Avoid social 
interactions, rumours and stigmatization, Mask wearing, 
Aware about COVID & Adopt ayurveda Immunity 
measures for self-care, Social distancing & self-hygiene, 
Testing and tracing & Etiquette (hand & respiratory). 
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